On November 23rd, the Active Pharmaceutical Ingredients Registration Coordination (COIFA) of Anvisa held a Workshop to discuss the DIFA/CADIFA topic and the regulations related to Active Pharmaceutical Ingredients (RDC 359/20, RDC 361/20, and RDC 654/22).